|
1
|
Teh E and Belcher E: Lung cancer:
Diagnosis, staging and treatment. Surgery. 32:242–248. 2014.
|
|
2
|
Stewart BW and Wild CP: World Cancer
Report 2014. World Health Organization; Lyon: 2014
|
|
3
|
Lu C, Onn A and Vaporciyan A: 78: Cancer
of the Lung. Holland-Frei Cancer Medicine. 8th edition. People's
Medical Publishing House; 2010
|
|
4
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frazier TP and Zhang B: Identification of
plant microRNAs using expressed sequence tag analysis. Plant
Reverse Genetics. Springer; pp. 13–25. 2011, View Article : Google Scholar
|
|
6
|
Schneider MR: MicroRNAs as novel players
in skin development, homeostasis and disease. Br J Dermatol.
166:22–28. 2012. View Article : Google Scholar
|
|
7
|
Fu SW, Chen L and Man YG: miRNA biomarkers
in breast cancer detection and management. J Cancer. 2:116–122.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nicolas FE, Lopez-Gomollon S,
Lopez-Martinez AF and Dalmay T: Silencing human cancer:
Identification and uses of microRNAs. Recent Pat Anticancer Drug
Discov. 6:94–105. 2011. View Article : Google Scholar
|
|
9
|
Patnaik SK, Yendamuri S, Kannisto E,
Kucharczuk JC, Singhal S and Vachani A: MicroRNA expression
profiles of whole blood in lung adenocarcinoma. PLoS One.
7:e460452012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao F, Chang J, Wang H and Zhang G:
Potential diagnostic value of miR-155 in serum from lung
adenocarcinoma patients. Oncol Rep. 31:351–357. 2014.
|
|
11
|
Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu
Z, Fang H, Zhang J, Katz RL and Jiang F: Early detection of lung
adenocarcinoma in sputum by a panel of microRNA markers. Int J
Cancer. 127:2870–2878. 2010. View Article : Google Scholar
|
|
12
|
Saito M, Schetter AJ, Mollerup S, Kohno T,
Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A, et
al: The association of microRNA expression with prognosis and
progression in early-stage, non-small cell lung adenocarcinoma: A
retrospective analysis of three cohorts. Clin Cancer Res.
17:1875–1882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Travis WD, Brambilla W, Mueller-Hermelink
HK and Harris CC: World Health Organization classification of
tumors: Pathology and Genetics of Tumors of the Lung, Pleura,
Thymus and Heart. IARC Press; Lyon: 2004
|
|
14
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th edition.
Wiley-Blackwell; 2009
|
|
15
|
Ohtsuka T, Nomori H, Watanabe K, Kaji M,
Naruke T, Suemasu K and Uno K: Prognostic significance of
[(18)F]fluorodeoxyglucose uptake on positron emission tomography in
patients with pathologic stage I lung adenocarcinoma. Cancer.
107:2468–2473. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao X, Gulari E and Zhou X: In situ
synthesis of oligonucleotide microarrays. Biopolymers. 73:579–596.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Streichert T, Otto B and Lehmann U:
MicroRNA profiling using fluorescence-labeled beads: data
acquisition and processing. MicroRNA and Cancer. Springer; pp.
253–268. 2011, View Article : Google Scholar
|
|
19
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
21
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID Gene Functional Classification Tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matys V, Kel-Margoulis OV, Fricke E,
Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M,
Hornischer K, et al: TRANSFAC and its module TRANSCompel:
Transcriptional gene regulation in eukaryotes. Nucleic Acids Res.
34:D108–D110. 2006. View Article : Google Scholar
|
|
23
|
Rosenbloom KR, Sloan CA, Malladi VS,
Dreszer TR, Learned K, Kirkup VM, Wong MC, Maddren M, Fang R,
Heitner SG, et al: ENCODE data in the UCSC Genome Browser: Year 5
update. Nucleic Acids Res. 41:D56–D63. 2013. View Article : Google Scholar :
|
|
24
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering
C, et al: STRING v9.1: Protein-protein interaction networks, with
increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar :
|
|
25
|
Smoot ME, Ono K, Ruscheinski J, Wang P-L
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar :
|
|
26
|
Barshack I, Lithwick-Yanai G, Afek A,
Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, Cohen L, Dan H, Zion
O, Strenov Y, et al: MicroRNA expression differentiates between
primary lung tumors and metastases to the lung. Pathol Res Pract.
206:578–584. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raponi M, Zhang Y, Yu J, Chen G, Lee G,
Taylor JM, Macdonald J, Thomas D, Moskaluk C, Wang Y, et al: Gene
expression signatures for predicting prognosis of squamous cell and
adenocarcinomas of the lung. Cancer Res. 66:7466–7472. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim MK, Jung SB, Kim JS, Roh MS, Lee JH,
Lee EH and Lee HW: Expression of microRNA miR-126 and miR-200c is
associated with prognosis in patients with non-small cell lung
cancer. Virchows Arch. 465:463–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jusufovic E, Keser D, Zukic E, Sejdinovic
R and Mrsic D: Downregulated anti-angiogenic miR-19a, miR-126 and
let-7b in non-small lung cancer have poor but different prognostic
values in squamous and adenocarcinoma subtypes. Eur Respir J.
42:46422013.
|
|
30
|
Liu B, Peng XC, Zheng X-L, Wang J and Qin
YW: miR-126 restoration down-regulate VEGF and inhibit the growth
of lung cancer cell lines in vitro and in vivo. Lung Cancer.
66:169–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Perrot V, Vázquez-Prado J and Gutkind JS:
Plexin B regulates Rho through the guanine nucleotide exchange
factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol
Chem. 277:43115–43120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li N, Tang A, Huang S, Li Z, Li X, Shen S,
Ma J and Wang X: miR-126 suppresses colon cancer cell proliferation
and invasion via inhibiting RhoA/ROCK signaling pathway. Mol Cell
Biochem. 380:107–119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Faried A, Faried LS, Kimura H, Nakajima M,
Sohda M, Miyazaki T, Kato H, Usman N and Kuwano H: RhoA and RhoC
proteins promote both cell proliferation and cell invasion of human
oesophageal squamous cell carcinoma cell lines in vitro and in
vivo. Eur J Cancer. 42:1455–1465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pillé JY, Denoyelle C, Varet J, Bertrand
JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP and Malvy C:
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and
invasiveness of MDA-MB-231 breast cancer cells in vitro and in
vivo. Mol Ther. 11:267–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vial E, Sahai E and Marshall CJ: ERK-MAPK
signaling coordinately regulates activity of Rac1 and RhoA for
tumor cell motility. Cancer Cell. 4:67–79. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vasiliev JM, Omelchenko T, Gelfand IM,
Feder HH and Bonder EM: Rho overexpression leads to
mitosis-associated detachment of cells from epithelial sheets: A
link to the mechanism of cancer dissemination. Proc Natl Acad Sci
USA. 101:12526–12530. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Võsa U, Vooder T, Kolde R, Vilo J,
Metspalu A and Annilo T: Meta-analysis of microRNA expression in
lung cancer. Int J Cancer. 132:2884–2893. 2013. View Article : Google Scholar
|
|
38
|
Guan P, Yin Z, Li X, Wu W and Zhou B:
Meta-analysis of human lung cancer microRNA expression profiling
studies comparing cancer tissues with normal tissues. J Exp Clin
Cancer Res. 31:542012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang R, Wang ZX, Yang JS, Pan X, De W and
Chen LB: MicroRNA-451 functions as a tumor suppressor in human
non-small cell lung cancer by targeting ras-related protein 14
(RAB14). Oncogene. 30:2644–2658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He Q, Chen J, Lin HL, Hu PJ and Chen MH:
Expression of peroxisome proliferator-activated receptor gamma,
E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and
lymph node metastases. Chin Med J (Engl). 120:1498–1504. 2007.
|
|
41
|
Inoue K, Kawahito Y, Tsubouchi Y, Yamada
R, Kohno M, Hosokawa Y, Katoh D, Bishop-Bailey D, Hla T and Sano H:
Expression of peroxisome proliferator-activated receptor
(PPAR)-gamma in human lung cancer. Anticancer Res. 21:2471–2476.
2001.PubMed/NCBI
|
|
42
|
Tsubouchi Y, Sano H, Kawahito Y, Mukai S,
Yamada R, Kohno M, Inoue K, Hla T and Kondo M: Inhibition of human
lung cancer cell growth by the peroxisome proliferator-activated
receptor-gamma agonists through induction of apoptosis. Biochem
Biophys Res Commun. 270:400–405. 2000. View Article : Google Scholar
|
|
43
|
Takamochi K, Ogura T, Yokose T, Ochiai A,
Nagai K, Nishiwaki Y, Suzuki K and Esumi H: Molecular analysis of
the TSC1 gene in adenocarcinoma of the lung. Lung Cancer.
46:271–281. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liang MC, Ma J, Chen L, Kozlowski P, Qin
W, Li D, Goto J, Shimamura T, Hayes DN, Meyerson M, et al: TSC1
loss synergizes with KRAS activation in lung cancer development in
the mouse and confers rapamycin sensitivity. Oncogene.
29:1588–1597. 2010. View Article : Google Scholar :
|
|
45
|
Yang Z, Chen S, Luan X, Li Y, Liu M, Li X,
Liu T and Tang H: MicroRNA-214 is aberrantly expressed in cervical
cancers and inhibits the growth of HeLa cells. IUBMB Life.
61:1075–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang XJ, Ye H, Zeng CW, He B, Zhang H and
Chen YQ: Dysregulation of miR-15a and miR-214 in human pancreatic
cancer. J Hematol Oncol. 3:462010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar
|
|
48
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ishimura M, Sakurai-Yageta M, Maruyama T,
Ando T, Fukayama M, Goto A and Murakami Y: Involvement of miR-214
and miR-375 in malignant features of non-small-cell lung cancer by
down-regulating CADM1. J Cancer Ther. 3:379–387. 2012. View Article : Google Scholar
|
